Intuitive Surgical, Inc. (ISRG)
Healthcare · end-of-day data as of Oct 16, 2026
The average 12-month analyst price target for ISRG is $478.50, 12.1% above the last close of $426.70 on Oct 16, 2026; targets range from $355.93 to $747.40. Rating consensus: Buy.
Snapshot
- P/E48.5x
- P/E vs sector+72.4%
- P/E vs own-16.3%
- Target upside+12.1%
- ConsensusBuy
- Market cap$151B
- FCF yield+2.1%
- Insiders-$4.78M
- Earnings in4d
- News
Why it moved
Intuitive Surgical, Inc. (ISRG) fell 0.3% on Oct 16, 2026.
The market (SPY) fell 1.1%; Healthcare stocks fell 0.7%. Most of the move came from the market as a whole.
News spike: 4 stories, 3.2× the 30-day average.
- Forget AI Stocks: Buy Med-Tech Stock ISRG Now for 40% Upside
- Intuitive Surgical, Inc. $ISRG Stock: Banque Pictet & Cie SA Cuts Holdings
- First Week of Q3 Earnings in the Books
Market = SPY. Sector = equal-weight average of the tracked companies in the same sector, net of the market.
Price and events
Last close $426.70 · -1.8% over 1y · E earnings · D dividend · S split · A analyst rating change
Technicals
- Trendsideways
- Sector▲ +16.0%
- MAs20▲ 50▲ 100▲ 200▼
- Above MAs3 of 4 above
- MA20×50—
- RSI65
- Support-0.1%
- Resistance+4.9%
- Off 52w high-28.0%
- Off ATH-30.1%
- 52w range$426.70
- Bollingerupper half
- MACD1.13
- ATR+2.6%
- Volume1.3x
Analyst price targets
17 firms with a target in the last 12 months · last close $426.70 · as of Oct 16, 2026
Strong buy 8 · Buy 18 · Hold 7 · Sell 1 · Strong sell 0
Revenue and free cash flow
Q2 FY2026: Revenue +18.5% year over year, free cash flow 32.8% of revenue, operating margin 33.6%.
| Q2 FY2026 | Jun 30, 2026 | $2.89B | 2.35 | $948M | 67.8% | 33.6% | 28.3% |
| Q1 FY2026 | Mar 31, 2026 | $2.77B | 2.28 | $809M | 66.1% | 30.9% | 29.6% |
| Q4 FY2025 | Dec 31, 2025 | $2.87B | 2.21 | $730M | 66.4% | 30.2% | 27.7% |
| Q3 FY2025 | Sep 30, 2025 | $2.51B | 1.95 | $736M | 66.4% | 30.3% | 28.1% |
| Q2 FY2025 | Jun 30, 2025 | $2.44B | 1.81 | $560M | 66.3% | 30.5% | 27.0% |
| Q1 FY2025 | Mar 31, 2025 | $2.25B | 1.92 | $465M | 64.7% | 25.7% | 31.0% |
| Q4 FY2024 | Dec 31, 2024 | $2.41B | 1.88 | $511M | 68.0% | 30.4% | 28.4% |
| Q3 FY2024 | Sep 30, 2024 | $2.04B | 1.56 | $459M | 67.4% | 28.3% | 27.7% |
Peers
| 20D | ||||||||
|---|---|---|---|---|---|---|---|---|
| 1 |  | $229.04 | -1.1% | -4.8% | +2.8% | 40.7 | $161B | |
| 2 | | $426.70 | -0.3% | -28.0% | +12.1% | 48.5 | $151B | |
| 3 |  | $191.75 | -1.0% | -1.0% | -6.2% | 57.8 | $52.23B | |
| 4 |  | $238.97 | -1.3% | -12.7% | +3.7% | 23.0 | $33.61B | |
| 5 |  | $384.02 | +0.3% | 0.0% | +1.9% | 49.1 | $27.03B | |
| 6 |  | $85.81 | -2.3% | -7.2% | +3.6% | 10.5 | $14.61B | |
| 7 |  | $25.28 | -1.9% | -10.8% | -14.8% | — | $13.07B | |
| 8 |  | $57.94 | +0.9% | -31.3% | +0.9% | 19.8 | $11.02B |
Data as of Oct 16, 2026 close.
Latest news
Sentiment classified by AI from the headline (green positive, red negative). Links open the publisher.